Glenmark Pharmaceuticals Ltd. (GLENMARK)
Market Closed
15 Oct, 10:00 PM
MSE XNSE Primary MSE ₹
2,250. 30
+5.8
+0.2584%
₹
- Market Cap
- P/E Ratio
10% Div Yield
10,742 Volume
- Eps
₹ 2,244.5
Previous Close Want to track GLENMARK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Glenmark Pharmaceuticals Ltd. (GLENMARK) Statistics
Valuation metrics
Market Cap -
Enterprise value 641.26B
Trailing P/E (ttm) 35.99
Forward P/E -
PEG ratio 0.26
Price/Sales (ttm) 3.65
Price/Book (mrq) 6.16
Enterprise Value/Revenue 3.62
Enterprise Value/EBITDA 19.12
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 23.44K
Average volume (90 days) 20.85K
Price summary
52-Week low 1,794
52-Week high 2,536.85
Beta -
50-Day moving average 2,398.43
200-Day moving average 2,287.13
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 5
Trailing annual dividend yield 0.0022%
5-Year annual dividend yield -
Payout ratio 0
Dividend Date 11 Oct 2026
Ex-Dividend Date 31 Aug 2026
Last split factor 2:1
Last split Date 10 Sep 2007
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.1%
Operating margin 0.2%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 628.51
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 63.71
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 41.68
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 1.77%
Book value per share (mrq) 372.49
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
